Cellebrite DI Ltd. CLBT
10.79
(0.58)
(5.10%)
as of 25 Sep
- Market cap
- $2.9B
- P/E
- 45.0×
Follow CLBT
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
56.34 | 0.00 | 0.00 | 7.06 | 18.66 | 0.00 | 0.00 | — |
P/S ratio |
9.16 | 11.50 | 4.93 | 3.05 | 4.69 | 0.00 | 0.00 | — |
P/FCF ratio |
402.64 | 38.84 | 18.02 | 60.36 | 37.33 | 0.00 | 0.00 | — |
P/Operating CF |
50.18 | 69.95 | 36.57 | 23.10 | 38.77 | (1,635.43) | 34.65 | — |
P/B ratio |
9.00 | 13.73 | 46.86 | 11.18 | 0.00 | 1.49 | 238.37 | — |
Price to Tangible BV |
15.38 | 15.59 | 0.00 | 23.08 | 0.00 | 1.53 | 238.37 | — |
EV/Sales |
8.24 | 10.39 | 4.00 | 2.37 | 3.95 | 0.00 | 0.00 | — |
EV/EBITDA |
51.59 | 64.50 | 30.85 | 65.09 | 46.73 | 0.00 | 0.00 | — |
EV/Operating CF |
22.58 | 31.53 | 12.74 | 31.21 | 27.00 | 0.00 | 0.00 | — |
EV/FCF |
362.24 | 35.08 | 14.62 | 46.94 | 31.46 | 0.00 | 0.00 | — |
Quick Ratio |
1.47 | 1.79 | 1.50 | 1.26 | 1.34 | 1.94 | — | — |
Current Ratio |
1.56 | 1.92 | 1.66 | 1.42 | 1.46 | 2.03 | — | — |
Net Debt/EBITDA |
(5.75) | (6.92) | (7.19) | (18.61) | (8.72) | (16.08) | 0.00 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.58 | 0.66 | 0.69 | 0.73 | 0.70 | 1.07 | 0.00 | — |
Operating CF/Net income |
2.22 | (0.47) | (1.26) | 0.18 | 0.51 | (7.12) | (1.61) | — |
Capex/Depreciation |
(16.92) | (1.73) | (0.89) | (1.03) | (1.16) | (1.05) | (1.52) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 19.10% | (152.88%) | (150.08%) | 44,830.50% | (1,476.12%) | (4.08%) | 0.00% | — | |
| 9.61% | (46.26%) | (17.33%) | 31.25% | 20.00% | (5.13%) | 0.00% | — | |
ROIC |
87.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
34.29% | (97.90%) | (44.04%) | 110.15% | 68.12% | (5.16%) | 0.00% | — |
Average Days of Receivables |
80.55 | 74.93 | 86.75 | 106.22 | 100.06 | 124.20 | 0.00 | — |
Research and Development Expense of Revenue |
23.94% | 24.53% | 25.96% | 29.79% | 26.62% | 27.90% | 27.10% | — |
Selling, General and Administrative Expense of Revenue |
46.28% | 45.68% | 47.45% | 51.08% | 50.49% | 47.94% | 52.94% | — |
Intangible Assets out of Total Assets |
0.21 | 0.06 | 0.07 | 0.09 | 0.11 | 0.04 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
9.44% | 7.62% | 5.84% | 5.06% | 2.63% | 3.73% | 7.42% | — |
Graham Net Nets |
0.03 | 0.05 | (0.05) | (0.04) | (0.12) | (0.09) | (0.50) | — |
Graham Number |
3.80 | 0.00 | 0.00 | 2.41 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
1.77% | (6.31%) | (5.10%) | 14.16% | 5.36% | 0.00% | 0.00% | — |
Free Cash Flow Yield |
0.25% | 2.57% | 5.55% | 1.66% | 2.68% | 0.00% | 0.00% | — |
Revenue per Share |
1.97 | 1.92 | 1.71 | 1.48 | 1.71 | 1.58 | 1.41 | — |
Operating CF per Share |
0.72 | 0.63 | 0.54 | 0.11 | 0.25 | 0.54 | 0.13 | — |
Capex per Share |
(0.66) | (0.06) | (0.04) | (0.05) | (0.06) | (0.05) | (0.05) | — |
Free Cash Flow per Share |
0.05 | 0.57 | 0.50 | 0.06 | 0.19 | 0.49 | 0.08 | — |
Cash per Share |
1.81 | 2.14 | 1.59 | 1.01 | 1.26 | 1.96 | 0.00 | — |
Shareholders Equity per Share |
2.00 | 1.60 | 0.18 | 0.40 | (0.51) | 0.52 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
2.00 | 1.60 | 0.18 | 0.40 | (0.51) | 0.52 | 0.00 | — |
Free Cash Flow |
12.86 | 118.81 | 94.14 | 11.49 | 27.94 | 60.33 | 9.92 | — |
Working Capital |
206.19 | 272.09 | 168.26 | 88.15 | 86.64 | 164.89 | — | — |
Capital Expenditures |
(160.68) | (13.36) | (7.92) | (9.08) | (8.11) | (6.18) | (6.21) | — |
Net Current Asset Value |
121.32 | 213.05 | (76.59) | (33.50) | (139.92) | 23.69 | 0.00 | — |
EV/EBIT |
58.96 | 73.23 | 39.12 | 615.09 | 70.42 | 0.00 | 0.00 | — |
Capex to Sales |
0.34 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | — |
Net Profit Margin |
16.47% | (70.54%) | (24.95%) | 42.90% | 28.60% | (4.79%) | (5.84%) | — |
Price to Operating Income |
65.53 | 81.09 | 48.23 | 790.97 | 83.55 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.43 | 0.45 | 0.56 | 0.51 | 0.42 | 0.37 | 0.00 | — |
Cash ROIC |
16.43% | 14.71% | 25.56% | 1.29% | 17.83% | 16.44% | 0.00% | — |
Accounts Receivable Turnover |
5.08 | 5.03 | 4.17 | 3.70 | 3.68 | 2.91 | 0.00 | — |
Accounts Payable Turnover |
0.93 | 0.98 | 1.03 | 0.89 | 0.72 | 0.65 | 0.00 | — |
Inventory Turnover |
9.09 | 6.63 | 5.29 | 6.08 | 7.56 | 6.73 | 0.00 | — |
Average Days of Payables |
427.67 | 433.89 | 364.29 | 360.10 | 545.39 | 518.79 | 0.00 | — |
Days of Inventory on Hand |
36.92 | 52.13 | 68.16 | 73.19 | 55.84 | 45.81 | 0.00 | — |
Average Receivables |
93.67 | 79.81 | 78.02 | 73.13 | 66.91 | 66.91 | — | — |
Average Payables |
81.24 | 63.77 | 51.60 | 56.83 | 58.71 | 58.71 | — | — |
Average Inventory |
8.27 | 9.44 | 10.06 | 8.34 | 5.63 | 5.63 | — | — |
Average Assets |
814.71 | 611.73 | 468.09 | 371.54 | 352.09 | 182.19 | 0.00 | — |
Average Common Equity |
410.17 | 185.12 | 54.04 | 0.26 | (4.77) | 229.20 | — | — |
Columns are period end dates